Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 4
2005 3
2006 4
2007 7
2008 4
2009 8
2010 9
2011 12
2012 10
2013 13
2014 13
2015 12
2016 14
2017 14
2018 12
2019 13
2020 21
2021 6
2022 10
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
RGD-Based Fluorescence to Assess Placental Angiogenesis.
Josserand V, Lavaud J, Keramidas M, Collet C, Traboulsi W, Hoffmann P, Feige JJ, Benharouga M, Coll JL, Alfaidy N. Josserand V, et al. Among authors: coll jl. Methods Mol Biol. 2024;2728:131-136. doi: 10.1007/978-1-0716-3495-0_11. Methods Mol Biol. 2024. PMID: 38019397
Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma.
Castillo-Ferrer C, Marguet T, Vanwonterghem L, Erbek S, Chuffart F, Mouret S, Messai ST, Gauchez AS, Coll JL, Charles J, Hurbin A, Martel-Frachet V. Castillo-Ferrer C, et al. Among authors: coll jl. J Invest Dermatol. 2024 Feb;144(2):422-426.e8. doi: 10.1016/j.jid.2023.07.016. Epub 2023 Aug 12. J Invest Dermatol. 2024. PMID: 37580013 No abstract available.
Correction to: VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop.
Boudria A, Faycal CA, Jia T, Gout S, Keramidas M, Didier C, Lemaître N, Manet S, Coll JL, Toffart AC, Moro-Sibilot D, Albiges-Rizo C, Josserand V, Faurobert E, Brambilla C, Brambilla E, Gazzeri S, Eymin B. Boudria A, et al. Among authors: coll jl. Oncogene. 2023 Aug;42(32):2471-2472. doi: 10.1038/s41388-023-02764-w. Oncogene. 2023. PMID: 37407792 No abstract available.
Intracellular accumulation and immunological response of NIR-II polymeric nanoparticles.
Moskalevska I, Faure V, Haye L, Mercey-Ressejac M, Dey AK, Chovelon B, Soro LK, Charbonnière LJ, Reisch A, Klymchenko AS, Marche PN, Coll JL, Macek Jilkova Z, le Guével X. Moskalevska I, et al. Among authors: coll jl. Int J Pharm. 2023 Jan 5;630:122439. doi: 10.1016/j.ijpharm.2022.122439. Epub 2022 Nov 26. Int J Pharm. 2023. PMID: 36503846
168 results